US Stock MarketDetailed Quotes

Candel Therapeutics (CADL)

Watchlist
  • 5.160
  • +0.010+0.19%
Close Apr 16 15:59 ET
  • 5.200
  • +0.040+0.78%
Post 20:01 ET
377.95MMarket Cap-7.17P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Candel Therapeutics (CADL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-41.77%-38.31M
-81.77%-10.57M
-55.73%-10.24M
-43.45%-8.89M
-2.11%-8.62M
21.09%-27.02M
21.67%-5.81M
25.37%-6.57M
13.86%-6.2M
22.01%-8.44M
Net income from continuing operations
30.80%-38.18M
-109.59%-29.5M
-5.85%-11.27M
78.43%-4.8M
189.76%7.38M
-45.44%-55.18M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
Operating gains losses
-137.94%-7.89M
131.24%13.49M
-149.94%-818K
-142.58%-5.68M
-212,485.71%-14.88M
2,445.21%20.8M
1,102.47%5.83M
383.39%1.64M
9,363.19%13.34M
98.92%-7K
Depreciation and amortization
-14.65%845K
-33.47%163K
-20.41%195K
-2.81%242K
-2.39%245K
3.13%990K
-1.61%245K
0.00%245K
5.51%249K
9.13%251K
Other non cash items
23.53%819K
151.30%387K
-16.05%136K
-14.79%144K
-14.61%152K
-0.45%663K
-12.00%154K
-4.71%162K
3.68%169K
12.66%178K
Change In working capital
533.82%2.19M
383.85%3.6M
-57.82%356K
-84.81%67K
-8.50%-1.83M
165.90%346K
-53.48%743K
179.77%844K
-69.18%441K
32.59%-1.68M
-Change in prepaid assets
-317.09%-508K
218.83%1.2M
124.80%61K
-1,464.79%-1.94M
528.21%167K
-53.48%234K
-48.57%377K
62.10%-246K
-87.64%142K
94.66%-39K
-Change in payables and accrued expense
434.27%3.06M
375.82%2.32M
-61.78%464K
427.48%2.13M
-21.32%-1.86M
323.44%572K
-56.35%488K
506.02%1.21M
-28.62%404K
6.52%-1.53M
-Change in other current assets
-145.28%-24K
-116.67%-2K
-766.67%-40K
-38.10%13K
-64.29%5K
145.69%53K
-47.83%12K
-70.00%6K
113.21%21K
--14K
-Change in other current liabilities
0.78%-509K
21.64%-105K
0.77%-129K
-10.32%-139K
-10.57%-136K
-10.56%-513K
-10.74%-134K
-10.17%-130K
-11.50%-126K
-9.82%-123K
-Change in other working capital
--178K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-41.77%-38.31M
-81.77%-10.57M
-55.73%-10.24M
-43.45%-8.89M
-2.11%-8.62M
21.09%-27.02M
21.67%-5.81M
25.37%-6.57M
13.86%-6.2M
22.01%-8.44M
Investing cash flow
Cash flow from continuing investing activities
-3,400.00%-560K
-13,533.33%-409K
-117K
-416.67%-31K
57.14%-3K
94.29%-16K
88.89%-3K
0
96.45%-6K
-136.84%-7K
Net PPE purchase and sale
-3,400.00%-560K
-13,533.33%-409K
---117K
-416.67%-31K
57.14%-3K
94.29%-16K
88.89%-3K
--0
96.45%-6K
-136.84%-7K
Cash from discontinued investing activities
Investing cash flow
-3,400.00%-560K
-13,533.33%-409K
---117K
-416.67%-31K
57.14%-3K
94.29%-16K
88.89%-3K
--0
96.45%-6K
-136.84%-7K
Financing cash flow
Cash flow from continuing financing activities
-40.50%56.1M
-52.24%43.9M
-301.01%-3.37M
796.86%17.44M
-49.00%-1.87M
78,017.36%94.28M
76,061.16%91.91M
1.68M
1.95M
-1.26M
Net issuance payments of debt
495.04%36.21M
1,848.52%43.71M
0.00%-2.5M
0.00%-2.5M
-49.97%-2.5M
---9.17M
---2.5M
---2.5M
---2.5M
---1.67M
Net common stock issuance
-80.97%19.37M
--0
-117.50%-713K
470.13%19.7M
106.45%384K
--101.76M
--94.04M
--4.07M
--3.46M
--186K
Proceeds from stock option exercised by employees
-69.45%516K
-98.92%4K
-80.58%20K
-75.15%246K
8.85%246K
--1.69M
--370K
--103K
--990K
--226K
Cash from discontinued financing activities
Financing cash flow
-40.50%56.1M
-52.24%43.9M
-301.01%-3.37M
796.86%17.44M
-49.00%-1.87M
78,017.36%94.28M
76,061.16%91.91M
--1.68M
--1.95M
---1.26M
Net cash flow
Beginning cash position
188.46%102.92M
418.48%87.23M
364.79%100.95M
255.79%92.43M
188.46%102.92M
-49.26%35.68M
-61.10%16.82M
-58.36%21.72M
-56.36%25.98M
-49.26%35.68M
Current changes in cash
-74.38%17.23M
-61.77%32.92M
-180.31%-13.72M
300.09%8.52M
-8.13%-10.49M
294.09%67.24M
1,237.33%86.1M
45.06%-4.9M
42.16%-4.26M
10.19%-9.7M
End cash Position
16.74%120.15M
16.74%120.15M
418.48%87.23M
364.79%100.95M
255.79%92.43M
188.46%102.92M
188.46%102.92M
-61.10%16.82M
-58.36%21.72M
-56.36%25.98M
Free cash flow
-43.86%-38.9M
-88.71%-10.98M
-57.92%-10.38M
-43.81%-8.92M
-2.06%-8.62M
22.08%-27.04M
22.12%-5.82M
26.24%-6.57M
15.75%-6.2M
22.93%-8.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -41.77%-38.31M-81.77%-10.57M-55.73%-10.24M-43.45%-8.89M-2.11%-8.62M21.09%-27.02M21.67%-5.81M25.37%-6.57M13.86%-6.2M22.01%-8.44M
Net income from continuing operations 30.80%-38.18M-109.59%-29.5M-5.85%-11.27M78.43%-4.8M189.76%7.38M-45.44%-55.18M-26.84%-14.07M-26.21%-10.65M-131.30%-22.24M6.53%-8.22M
Operating gains losses -137.94%-7.89M131.24%13.49M-149.94%-818K-142.58%-5.68M-212,485.71%-14.88M2,445.21%20.8M1,102.47%5.83M383.39%1.64M9,363.19%13.34M98.92%-7K
Depreciation and amortization -14.65%845K-33.47%163K-20.41%195K-2.81%242K-2.39%245K3.13%990K-1.61%245K0.00%245K5.51%249K9.13%251K
Other non cash items 23.53%819K151.30%387K-16.05%136K-14.79%144K-14.61%152K-0.45%663K-12.00%154K-4.71%162K3.68%169K12.66%178K
Change In working capital 533.82%2.19M383.85%3.6M-57.82%356K-84.81%67K-8.50%-1.83M165.90%346K-53.48%743K179.77%844K-69.18%441K32.59%-1.68M
-Change in prepaid assets -317.09%-508K218.83%1.2M124.80%61K-1,464.79%-1.94M528.21%167K-53.48%234K-48.57%377K62.10%-246K-87.64%142K94.66%-39K
-Change in payables and accrued expense 434.27%3.06M375.82%2.32M-61.78%464K427.48%2.13M-21.32%-1.86M323.44%572K-56.35%488K506.02%1.21M-28.62%404K6.52%-1.53M
-Change in other current assets -145.28%-24K-116.67%-2K-766.67%-40K-38.10%13K-64.29%5K145.69%53K-47.83%12K-70.00%6K113.21%21K--14K
-Change in other current liabilities 0.78%-509K21.64%-105K0.77%-129K-10.32%-139K-10.57%-136K-10.56%-513K-10.74%-134K-10.17%-130K-11.50%-126K-9.82%-123K
-Change in other working capital --178K------------------------------------
Cash from discontinued investing activities
Operating cash flow -41.77%-38.31M-81.77%-10.57M-55.73%-10.24M-43.45%-8.89M-2.11%-8.62M21.09%-27.02M21.67%-5.81M25.37%-6.57M13.86%-6.2M22.01%-8.44M
Investing cash flow
Cash flow from continuing investing activities -3,400.00%-560K-13,533.33%-409K-117K-416.67%-31K57.14%-3K94.29%-16K88.89%-3K096.45%-6K-136.84%-7K
Net PPE purchase and sale -3,400.00%-560K-13,533.33%-409K---117K-416.67%-31K57.14%-3K94.29%-16K88.89%-3K--096.45%-6K-136.84%-7K
Cash from discontinued investing activities
Investing cash flow -3,400.00%-560K-13,533.33%-409K---117K-416.67%-31K57.14%-3K94.29%-16K88.89%-3K--096.45%-6K-136.84%-7K
Financing cash flow
Cash flow from continuing financing activities -40.50%56.1M-52.24%43.9M-301.01%-3.37M796.86%17.44M-49.00%-1.87M78,017.36%94.28M76,061.16%91.91M1.68M1.95M-1.26M
Net issuance payments of debt 495.04%36.21M1,848.52%43.71M0.00%-2.5M0.00%-2.5M-49.97%-2.5M---9.17M---2.5M---2.5M---2.5M---1.67M
Net common stock issuance -80.97%19.37M--0-117.50%-713K470.13%19.7M106.45%384K--101.76M--94.04M--4.07M--3.46M--186K
Proceeds from stock option exercised by employees -69.45%516K-98.92%4K-80.58%20K-75.15%246K8.85%246K--1.69M--370K--103K--990K--226K
Cash from discontinued financing activities
Financing cash flow -40.50%56.1M-52.24%43.9M-301.01%-3.37M796.86%17.44M-49.00%-1.87M78,017.36%94.28M76,061.16%91.91M--1.68M--1.95M---1.26M
Net cash flow
Beginning cash position 188.46%102.92M418.48%87.23M364.79%100.95M255.79%92.43M188.46%102.92M-49.26%35.68M-61.10%16.82M-58.36%21.72M-56.36%25.98M-49.26%35.68M
Current changes in cash -74.38%17.23M-61.77%32.92M-180.31%-13.72M300.09%8.52M-8.13%-10.49M294.09%67.24M1,237.33%86.1M45.06%-4.9M42.16%-4.26M10.19%-9.7M
End cash Position 16.74%120.15M16.74%120.15M418.48%87.23M364.79%100.95M255.79%92.43M188.46%102.92M188.46%102.92M-61.10%16.82M-58.36%21.72M-56.36%25.98M
Free cash flow -43.86%-38.9M-88.71%-10.98M-57.92%-10.38M-43.81%-8.92M-2.06%-8.62M22.08%-27.04M22.12%-5.82M26.24%-6.57M15.75%-6.2M22.93%-8.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -